Biological Assessment of the NO-Dependent Endothelial Function

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 22; p. 7921
• Main Authors: Boughaleb, Hasnae, Lobysheva, Irina, Dei Zotti, Flavia, Balligand, Jean-Luc, Montiel, Virginie
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.11.2022; MDPI
• Subjects: Acids; Atherosclerosis; Bioavailability; Blood; Cardiovascular disease; Cardiovascular diseases; COVID-19; endothelial dysfunction; Endothelium; Endothelium, Vascular - metabolism; Enzymes; Glycosylated hemoglobin; HbNO; Heme; Hemoglobin; Hemoglobins - metabolism; Homeostasis; Humans; Hypertension; Kinases; Medical examination; Nitrates; Nitric oxide; Nitric Oxide - metabolism; Nitrogen; nitrosylated hemoglobin; NO bioavailability; NO-dependent endothelial function; Oxidation; Physiological aspects; Proteins; Review; Smooth muscle; Thrombosis; nitric oxide; nitrosylated hemoglobin; NO bioavailability; electron paramagnetic resonance spectroscopy; reactive oxygen species; HbNO; NO-dependent endothelial function; endothelial nitric oxide synthase; cardiovascular diseases; endothelial dysfunction
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27227921

Nitric oxide (NO) is implicated in numerous physiological processes, including vascular homeostasis. Reduced NO bioavailability is a hallmark of endothelial dysfunction, a prequel to many cardiovascular diseases. Biomarkers of an early NO-dependent endothelial dysfunction obtained from routine venous blood sampling would be of great interest but are currently lacking. The direct measurement of circulating NO remains a challenge due by its high reactivity and short half-life. The current techniques measure stable products from the NO signaling pathway or metabolic end products of NO that do not accurately represent its bioavailability and, therefore, endothelial function per se. In this review, we will concentrate on an original technique of low temperature electron paramagnetic resonance spectroscopy capable to directly measure the 5-α-coordinated heme nitrosyl-hemoglobin in the T (tense) state (5-α-nitrosyl-hemoglobin or HbNO) obtained from fresh venous human erythrocytes. In humans, HbNO reflects the bioavailability of NO formed in the vasculature from vascular endothelial NOS or exogenous NO donors with minor contribution from erythrocyte NOS. The HbNO signal is directly correlated with the vascular endothelial function and inversely correlated with vascular oxidative stress. Pilot studies support the validity of HbNO measurements both for the detection of endothelial dysfunction in asymptomatic subjects and for the monitoring of such dysfunction in patients with known cardiovascular disease. The impact of therapies or the severity of diseases such as COVID-19 infection involving the endothelium could also be monitored and their incumbent risk of complications better predicted through serial measurements of HbNO.